Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 1.70B NGN in the quarter ending June 30, 2025, with 68.94% growth. This brings the company's revenue in the last twelve months to 5.74B, up 97.27% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.

• Revenue (ttm): 5.74B
• Revenue Growth: +97.27%
• P/S Ratio: 4.29
• Revenue / Employee: 29.28M
• Employees: 196
• Market Cap: 24.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.49B	2.28B	102.98%
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%
Sep 30, 2021	3.05B	207.54M	7.31%